article thumbnail

Pharmacist Salaries and Employment in 2023: The Grass Keeps Getting Greener in Hospitals

Drug Channels

Meanwhile, employment and salaries in non-retail settings—hospitals, physician offices, outpatient centers, and home healthcare—continued to grow. What’s ahead for 340B-eligible hospitals? Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. These settings now employ one in three U.S.

article thumbnail

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

As many of you know, hospitals and health systems have emerged as significant participants in the specialty pharmacy industry. A new American Society of Hospital Pharmacists (ASHP) survey provides fresh insights into these specialty pharmacies. I then highlight how hospitals steer prescriptions to their internal specialty pharmacies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacist Job Market in 2021: Retail Pharmacy Slump, Hospital Boom

Drug Channels

We found that retail pharmacies and drugstores employed fewer pharmacists, while hospitals and outpatient centers continued to add positions. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. As a result, the share of pharmacists who work in non-retail practice settings reached a new high. d/b/a Drug Channels Institute.

article thumbnail

White Bagging Update 2022: Hospitals Battle to Boost Buy-and-Bill

Drug Channels

However, buy-and-bill appears to have rebounded substantially at hospitals. As I explain below, this resurgence likely reflects the success of vertically-integrated hospital/specialty pharmacy/physician mega-systems against the large insurer/PBM/specialty pharmacy/provider mega-organizations. d/b/a Drug Channels Institute.

article thumbnail

Part B Update: Hospitals Keep Displacing Physicians—And More Practice Acquisitions Loom

Drug Channels

Medicare payments continued to their shift from physician practices to hospital outpatient departments. . This spending change would have been even more pronounced if CMS had not reduced reimbursements to 340B hospitals. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

article thumbnail

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money

Drug Channels

Hospitals accounted for 87% of these skyrocketing 340B purchases. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9 billion (+15.6%) higher than its 2020 counterpart. billion (+$7.0

article thumbnail

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money (rerun)

Drug Channels

Hospitals accounted for 87% of these skyrocketing 340B purchases. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9 billion (+15.6%) higher than its 2020 counterpart. billion (+$7.0